Affinity Asset Advisors, LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1773195
NEW YORK, NY
Position in VRDN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,890,000
-$2,890,000 QoQ
Shares Held
250,000
0.0% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Derivatives in VRDN
reported options exposure · as of Jun 30, 2023CallValue
$3,102,216
CallShares
130,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Affinity Asset Advisors, LLC holds $1,518,254,571 across 81 Biotechnology names. VRDN ranks #51 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,284,926 | $108,152,221 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
1,675,000 | $97,401,250 | |
| 3 | ERAS |
Erasca, Inc.
|
5,350,000 | $86,563,000 | |
| 4 | INSM |
INSMED Inc
|
480,000 | $78,489,600 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,800,000 | $77,560,000 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $64,519,518 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
1,400,000 | $55,608,000 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
170,000 | $54,772,300 |
All Filings in VRDN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,890,000 | 250,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,780,000 | 250,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,395,000 | 250,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,452,200 | 390,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,257,200 | 390,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,059,800 | 159,614 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,943,750 | 525,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,951,500 | 150,000 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,089,000 | 50,000 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $3,102,216 | 130,400 | Call | Sole | 2023-08-21 | |
| 2023-03-31 | $2,556,720 | 100,500 | Call | Sole | 2023-05-15 | |
| 2022-06-30 | $239,036 | 20,660 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $924,500 | 50,000 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||